From the bench to the clinic: New aspects on immunoregulation by vitamin D analogs

Dermato-Endocrinology

Volumn 3, Issue 3, 2011, Pages 187-192

  Sigmundsdottir, Hekla ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Dendritic cells; Regulatory T cells; Skin diseases; T cells; Treatment; Vitamin D

Indexed keywords

BETA DEFENSIN; CALCITRIOL; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLECALCIFEROL; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; ATOPIC DERMATITIS; CELL INTERACTION; CELL PROLIFERATION; DENDRITIC CELL; DISEASE SEVERITY; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; KERATINOCYTE; LYMPHOCYTE; NEUTROPHIL; NONHUMAN; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; SKIN INFLAMMATION; SUN EXPOSURE; T LYMPHOCYTE; ULTRAVIOLET B RADIATION;

EID: 80054011459     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.3.3.15115     Document Type: Review

References (70)

1. Gowans JL. The recirculation of lymphocytes from blood to lymph in the rat. J Physiol 1959; 146:54-69.
2. Shorter RG, Bollman JL. Experimental transfusion of lymphocytes. Am J Physiol 1960; 198:1014-8.
3. Cahill RN, Poskitt DC, Frost DC, Trnka Z. Two distinct pools of recirculating T lymphocytes: migratory characteristics of nodal and intestinal T lymphocytes. J Exp Med 1977; 145:420-8. (Pubitemid 8032095)
4. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67:1033-6. (Pubitemid 121001517)
5. Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK, et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991; 174:1461-6.
6. Picker LJ, Michie SA, Rott LS, Butcher EC. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990; 136:1053-68. (Pubitemid 20188492)
7. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 400:776-80. (Pubitemid 29399540)
8. Campbell JJ, O'Connell DJ, Wurbel MA. Cutting edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. J Immunol 2007; 178:3358-62. (Pubitemid 46417598)
9. Pivarcsi A, Homey B. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr Allergy Asthma Rep 2005; 5:284-90. (Pubitemid 41149708)
10. Homey B, Alenius H, Müller A, Soto H, Bowman EP, Yuan W, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8:157-65. (Pubitemid 34155127)
11. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC Chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001; 194:1541-7. (Pubitemid 33081528)
12. Huang V, Lonsdorf AS, Fang L, Kakinuma T, Lee VC, Cha E, et al. Cutting edge: Rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cells. J Immunol 2008; 180:6462-6.
13. Gros E, Bussmann C, Bieber T, Forster I, Novak N. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol 2009; 124:753-60.
14. Nakagami Y, Kawashima K, Yonekubo K, Etori M, Jojima T, Miyazaki S, et al. Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice. Eur J Pharmacol 2009; 624:38-44.
15. Parham M, Yi-Yang Yvonne L, Nicole B, Khusru A, Thomas MZ. CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity. Exper Dermatol 2008; 17:30-4.
16. Pan J, Kunkel EJ, Gosslar U, Lazarus N, Langdon P, Broadwell K, et al. Cutting edge: A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 2000; 165:2943-9.
17. Kagami S, Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Sasaki K, et al. Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis sulgaris and bullous pemphigoid. J Investig Dermatol 2005; 124:1088-90. (Pubitemid 40629119)
18. Schauber J, Gallo RL. The vitamin D pathway: a new target for control of the skin's immune response? Exper Dermatol 2008; 17:633-9. (Pubitemid 352044354)
19. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004; 29:664-73. (Pubitemid 39491265)
20. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8:685-98.
21. 3in human skin equivalents. Exper Dermatol 2000; 9:97-103.
22. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-3.
23. Kragballe K, Wildfang IL. Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 1990; 282:164-7. (Pubitemid 20155219)
24. 3 in the immune system. J Steroid Biochem Mol Biol 2010; 121:221-7.
25. 3and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett 2010; 134:7-16.
26. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol 2002; 32:1445-54. (Pubitemid 34546273)
27. Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003; 424:88-93. (Pubitemid 36834847)
28. Dudda JC, Lembo A, Bachtanian E, Huehn J, Siewert C, Hamann A, et al. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments. Eur J Immunol 2005; 35:1056-65. (Pubitemid 40542212)
29. Mora JR, Cheng G, Picarella D, Briskin M, Buchanan N, von Andrian UH. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin-and gut-associated lymphoid tissues. J Exp Med 2005; 201:303-16. (Pubitemid 40189439)
30. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004; 21:527-38. (Pubitemid 39370508)
31. Molenaar R, Greuter M, van der Marel AP, Roozendaal R, Martin SF, Edele F, et al. Lymph node stromal cells support dendritic cell-induced gut-homing of T cells. J Immunol 2009; 183:6395-402.
32. Hammerschmidt SI, Ahrendt M, Bode U, et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med 2008; 205:2483-90.
33. 3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007; 8:285-93.
34. Valdimarsson H, Bake BS, Jonsdotdr I, Fry L. Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytes. Immunology Today 1986; 7:256-9. (Pubitemid 17022412)
35. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 1998; 111:645-9. (Pubitemid 28452327)
36. Kryczek I, Bruce AT, Gudjonsson JE, Johnston A, Aphale A, Vatan L, et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 2008; 181:4733-41.
37. Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2010; 130:1373-83.
38. Res PC, Piskin G, de Boer OJ, van der Loos CM, Teeling P, Bos JD, et al. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS ONE 2010; 5:14108.
39. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-{alpha} production. J Exp Med 2005; 202:135-43. (Pubitemid 41002916)
40. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449:564-9. (Pubitemid 47525141)
41. Neis MM, Peters B, Dreuw A, Wenzel J, Bieber T, Mauch C, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006; 118:930-7. (Pubitemid 44498762)
42. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006; 117:418-25. (Pubitemid 43190155)
43. Gombert M, Dieu-Nosjean MC, Winterberg F, Bünemann E, Kubitza RC, Da Cunha L, et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 2005; 174:5082-91.
44. Norris D. Mechanisms of action of topical therapies and the rationale for combination therapy. J Am Acad Dermatol 2005; 53:17-25.
45. Kircik L. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis. J Drugs Dermatol 2009; 8:9-16.
46. Abramovits W. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy. J Drugs Dermatol 2009; 8:17-22.
47. White JH. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: Past, present and future. J Steroid Biochem Mol Biol 2010; 121:234-8.
48. Peric M, Koglin S, Dombrowski Y, Gross K, Bradac E, Büchau A, et al. Vitamin D analogs differentially control antimicrobial peptide/ "alarmin" expression in psoriasis. PLoS ONE 2009; 4:6340.
49. Heilborn JD, Weber G, Grönberg A, Dieterich C, Ståhle M. Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18/LL-37 during wounding in human skin in vivo. Exper Dermatol 2010; 19:332-8.
50. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008; 122:829-31.
51. Howell MD, Novak N, Bieber T, et al. Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis. J Investig Dermatol 2005; 125:738-45.
52. Matsui MS, Wang N, DeLeo VA. Ultraviolet radiation B induces differentiation and protein kinase C in normal human epidermal keratinocytes. Photodermatol Photoimmunol Photomed 1996; 12:103-8. (Pubitemid 26385211)
53. Sigmundsdottir H, Gudjonsson JE, Valdimarsson H. The effects of ultraviolet B treatment on the expression of adhesion molecules by circulating T lymphocytes in psoriasis. Br J Dermatol 2003; 148:996-1000. (Pubitemid 36750794)
54. Sigmundsdottir H, Johnston A, Gudjonsson J, Valdimarsson H. Narrowband UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells. Arch Dermatol Res 2005; 297:39-42. (Pubitemid 41380681)
55. Walters IB, Ozawa M, Cardinale I, Gilleaudeau P, Trepicchio WL, Bliss J, et al. Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch Dermatol 2003; 139:155-61. (Pubitemid 36216253)
56. Ozawa M, Ferenczi K, Kikuchi T, Cardinale I, Austin LM, Coven TR, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999; 189:711-8. (Pubitemid 29193372)
57. 3 metabolism differentially affects antimicrobial peptide expression in keratinocytes. J Allergy Clin Immunol 2010; 125:746-9.
58. Vähävihu K, Ala-Houhala M, Peric M, Karisola P, Kautiainen H, Hasan T, et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 2010; 163:321-8.
59. 3 and its analogues in psoriasis. Exper Opin Invest Drugs 1998; 7:77-84.
60. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164:2405-11. (Pubitemid 30115468)
61. 3 inhibits dendritic cell differentiation and maturation in vitro. Exper Hematol 2000; 28:575-83.
62. Pedersen AW, Holmstrøm K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P, et al. Phenotypic and functional markers for 1α,25- dihydroxyvitamin D3-modified regulatory dendritic cells. Clin Exper Immunol 2009; 157:48-59.
63. 3 and mycophenolate mofetil treatment mediate transplantation tolerance.J Immunol 2001; 167:1945-53.
64. Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007; 178:145-53. (Pubitemid 46033595)
65. Penna G, Amuchastegui S, Laverny G, Adorini L. Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells. J Bone Miner Res 2007; 22:69-73.
66. von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors K, Butcher EC. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci USA 1991; 88:7538-42.
67. Ghoreishi M, Bach P, Obst J, Komba M, Fleet JC, Dutz JP. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol 2009; 182:6071-8.
68. Gorman S, Kuritzky LA, Judge MA, Dixon KM, McGlade JP, Mason RS, et al. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J Immunol 2007; 179:6273-83.
69. low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol 2011; 186:132-42.
70. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: A study from the US population. J Amer Acad Dermatol 2004; 51:704-8. (Pubitemid 39516879)